Загрузка...
Glutamate and dopamine components in schizophrenia
The treatment of schizophrenia for the last half century has been with dopamine (DA) D(2) receptor blockers, implicating a hyperdopamine basis for psychosis. However, a 2007 report found that the glutamate agonist LY404039 was effective in schizophrenia, suggesting a hypoglutamate state for the illn...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Canadian Medical Association
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2647567/ https://ncbi.nlm.nih.gov/pubmed/19270765 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|